Should clopidogrel be discontinued before laparoscopic cholecystectomy?

Katherine Anderson, Daniel C. Jupiter, Stephen W. Abernathy, Richard C. Frazee

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Background The perioperative management of clopidogrel remains an area of controversy.

Methods An institutional review board-approved retrospective review of patients undergoing a laparoscopic cholecystectomy while on clopidogrel from 2008 to 2012 was performed. These patients were then matched with a nonclopidogrel cohort based on American Society of Anesthesiologists score and emergent or elective surgery. Intraoperative estimated blood loss, operative time, length of stay, and 30-day morbidity were compared.

Results Thirty-six clopidogrel and 36 control patient records were analyzed. There were no significant differences in age, body mass index, sex, or incidence of coronary artery disease, diabetes, hyperlipidemia, and congestive heart failure. Estimated blood loss averaged 50 mL in the clopidogrel group and 47 mL in the control group (P = nonsignificant). There were no significant differences in operative time, 30-day morbidity, or length of stay between the 2 groups.

Conclusions Laparoscopic cholecystectomy performed on patients maintained on clopidogrel during the perioperative period did not produce an increase in blood loss, operative time, 30-day morbidity, or length of stay.

Original languageEnglish (US)
Pages (from-to)926-931
Number of pages6
JournalAmerican Journal of Surgery
Volume208
Issue number6
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

Keywords

  • Bleeding complications
  • Laparoscopic cholecystectomy
  • Perioperative clopidogrel

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Should clopidogrel be discontinued before laparoscopic cholecystectomy?'. Together they form a unique fingerprint.

  • Cite this